Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome.
about
Editorial: diet, inflammation and irritable bowel syndrome.Existing and emerging therapies for managing constipation and diarrhea.A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo.Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling.The role of inflammation in irritable bowel syndrome (IBS)Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation
P2860
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Randomised clinical trial: the ...... n in irritable bowel syndrome.
@en
Randomised clinical trial: the ...... n in irritable bowel syndrome.
@nl
type
label
Randomised clinical trial: the ...... n in irritable bowel syndrome.
@en
Randomised clinical trial: the ...... n in irritable bowel syndrome.
@nl
prefLabel
Randomised clinical trial: the ...... n in irritable bowel syndrome.
@en
Randomised clinical trial: the ...... n in irritable bowel syndrome.
@nl
P2093
P2860
P50
P356
P1476
Randomised clinical trial: the ...... in in irritable bowel syndrome
@en
P2093
D DeFilippis
L Bellacosa
M Neunlist
R F Cogliandro
S Bruley des Varannes
S Petrosino
V Di Marzo
P2860
P304
P356
10.1111/APT.13958
P407
P577
2017-02-06T00:00:00Z